Join us on Oct. 15 from 11:00 a.m. – 12:00 p.m. ET for a webinar, held in tandem with release of a white paper summarizing findings from a Roundtable on Patient-Centered Multi-Criteria Decision Analysis (MCDA), co-hosted by the NHC and National Pharmaceutical Council earlier this year. Speakers will introduce MCDA and describe comments, suggestions, and takeaways that emerged during the discussion.

Researchers, value assessors, and the patient community agree that conventional approaches to value assessment often inadequately account for the many dimensions of value important to patients. Researchers have identified multi-criteria decision analysis (MCDA) as one promising approach to provide a more comprehensive measure of value.

Given substantial researcher interest in advancing its’ development and uptake, the National Health Council and National Pharmaceutical Council hosted a Roundtable to explore topics related to patient-centricity and MCDA. Join us for a webinar, held in tandem with the release of a corresponding white paper, to learn about the Roundtable discussions, including:

  • What is MCDA?
  • Can MCDA help make value assessment more patient-centered?
  • What are the opportunities and challenges associated with developing patient-centered MCDA?

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.